MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Rubius Therapeutics, Inc. (NASDAQ: RUBY)
*Key People: Rubius
Parents
Rubius Therapeutics, Inc. (NASDAQ: RUBY)
Children
2022: More biotechs hit the wall as Rubius lays off 82% of staff and Tricida seeks a sale_
2022: Rubius makes hard pivot after reviewing clinical data, dumping lead assets and laying off 75% of staffers
Co-founder of MRNA, Noubar Afeyan, has an enviable track record of bringing forth innovative companies and selling them off once its core product is proven.
Pablo J. Cagnoni, Rubius Therapeutics, Inc. - CEO, President & Director (2021)
Jumps
Finance & Acquisitions: Rubius
Organization & Developments: Rubius